Organon & Co. (OGN)
Total Valuation
Organon & Co. has a market cap or net worth of $4.81 billion. The enterprise value is $12.87 billion.
Market Cap | 4.81B |
Enterprise Value | 12.87B |
Important Dates
The last earnings date was Thursday, February 16, 2023, before market open.
Earnings Date | Feb 16, 2023 |
Ex-Dividend Date | Feb 23, 2024 |
Share Statistics
Organon & Co. has 255.64 million shares outstanding. The number of shares has increased by 0.43% in one year.
Shares Outstanding | 255.64M |
Shares Change (YoY) | +0.43% |
Shares Change (QoQ) | +0.10% |
Owned by Insiders (%) | 0.13% |
Owned by Institutions (%) | 79.70% |
Float | 254.96M |
Valuation Ratios
The trailing PE ratio is 4.71 and the forward PE ratio is 4.29.
PE Ratio | 4.71 |
Forward PE | 4.29 |
PS Ratio | 0.77 |
Forward PS | 0.74 |
PB Ratio | n/a |
P/FCF Ratio | 8.75 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.96, with an EV/FCF ratio of 23.45.
EV / Earnings | 12.58 |
EV / Sales | 2.06 |
EV / EBITDA | 8.96 |
EV / EBIT | 10.73 |
EV / FCF | 23.45 |
Financial Position
The company has a current ratio of 1.55
Current Ratio | 1.55 |
Quick Ratio | 0.84 |
Debt / Equity | n/a |
Debt / EBITDA | 6.10 |
Debt / FCF | 15.96 |
Interest Coverage | 2.28 |
Financial Efficiency
Return on equity (ROE) is -209.70% and return on invested capital (ROIC) is 21.73%.
Return on Equity (ROE) | -209.70% |
Return on Assets (ROA) | 9.10% |
Return on Capital (ROIC) | 21.73% |
Revenue Per Employee | $626,300 |
Profits Per Employee | $102,300 |
Employee Count | 10,000 |
Asset Turnover | 0.56 |
Inventory Turnover | 2.17 |
Taxes
Income Tax | -350.00M |
Effective Tax Rate | -52.01% |
Stock Price Statistics
The stock price has decreased by -15.47% in the last 52 weeks. The beta is 0.77, so Organon & Co.'s price volatility has been lower than the market average.
Beta (1Y) | 0.77 |
52-Week Price Change | -15.47% |
50-Day Moving Average | 17.47 |
200-Day Moving Average | 17.43 |
Relative Strength Index (RSI) | 61.65 |
Average Volume (30 Days) | 2,921,308 |
Short Selling Information
The latest short interest is 10.13 million, so 3.96% of the outstanding shares have been sold short.
Short Interest | 10.13M |
Short Previous Month | 13.34M |
Short % of Shares Out | 3.96% |
Short % of Float | 3.97% |
Short Ratio (days to cover) | 3.87 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.26 billion and earned $1.02 billion in profits. Earnings per share was $3.99.
Revenue | 6.26B |
Gross Profit | 3.75B |
Operating Income | 1.24B |
Pretax Income | 673.00M |
Net Income | 1.02B |
EBITDA | 1.44B |
EBIT | 1.20B |
Earnings Per Share (EPS) | $3.99 |
Balance Sheet
The company has $693.00 million in cash and $8.76 billion in debt, giving a net cash position of -$8.07 billion or -$31.56 per share.
Cash & Cash Equivalents | 693.00M |
Total Debt | 8.76B |
Net Cash | -8.07B |
Net Cash Per Share | -$31.56 |
Equity / Book Value | -70.00M |
Book Value Per Share | -0.27 |
Working Capital | 1.59B |
Cash Flow
In the last 12 months, operating cash flow was $799.00 million and capital expenditures -$250.00 million, giving a free cash flow of $549.00 million.
Operating Cash Flow | 799.00M |
Capital Expenditures | -250.00M |
Free Cash Flow | 549.00M |
FCF Per Share | $2.15 |
Margins
Gross margin is 59.84%, with operating and profit margins of 19.83% and 16.33%.
Gross Margin | 59.84% |
Operating Margin | 19.83% |
Pretax Margin | 10.75% |
Profit Margin | 16.33% |
EBITDA Margin | 22.93% |
EBIT Margin | 19.16% |
FCF Margin | 8.77% |
Dividends & Yields
This stock pays an annual dividend of $1.12, which amounts to a dividend yield of 5.96%.
Dividend Per Share | $1.12 |
Dividend Yield | 5.96% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 28.07% |
Buyback Yield | -0.43% |
Shareholder Yield | 5.53% |
Earnings Yield | 21.29% |
FCF Yield | 11.42% |
Analyst Forecast
The average price target for Organon & Co. is $22.50, which is 19.68% higher than the current price. The consensus rating is "Buy".
Price Target | $22.50 |
Price Target Difference | 19.68% |
Analyst Consensus | Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 1.81% |
EPS Growth Forecast (5Y) | -0.77% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.3 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.3 |
Piotroski F-Score | 4 |